Clinical Trial Update: Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip [Phase 3]

View source ↗

Summary

Phase 3 long-term safety and efficacy study of fasinumab in osteoarthritis of the knee or hip has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Fasinumab (fasinumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Osteoarthritis of the Knee or Hip | Phase 3 | Status: COMPLETED | Results posted: 2023-10-13